U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07914972) titled 'Treatment Pattern and Patient Outcomes Among Stage I-II Unresected NSCLC Patients' on Oct. 28.
Brief Summary: The iTERESA study is a retrospective, cross-sectional, non interventional, multi-country observational HCPs survey designed to characterize real-world management of adult patients with stage I-II unresected NSCLC.
Study Start Date: Oct. 30
Study Type: OBSERVATIONAL
Condition:
Non-small Cell Lung Cancer
NSCLC
Stage I-II Unresected NSCLC
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....